Skip to main content
Submitted by Dr S. Patel on 6 May 2017

This time in our health by numbers/tests series, Dr Shital Raval takes a look at our platelet count that can be determined by a routine blood test. If the platelet count is high or low from the normal range, it can provide insight into various abnormalities and blood disorders including infections and cancer.

A platelet count test is conducted to check the number of platelets in the blood. This test is usually a part of the CBC or complete blood count. Here is a look at what platelet count means.

What are platelets?

Platelets are plate-shaped cells found circulating in the blood. They are the cells responsible for blood clotting and being the first responders to any broken blood vessel. A platelet count can provide insight into various conditions that may affect efficient clotting such as bleeding disorders, infections, blood cancers etc.

When is it ordered?

If a person presents with any of the following symptoms or signs, a CBC with platelet count is ordered.

  • Frequent nosebleeds
  • Prolonged bleeding from wounds, gums or GI tract
  • Unexplained or easy bruising
  • Heavy menstrual flow
  • Petechiae (tiny red spots on the skin)
  • Purpura (purple spots due to bleeding under the skin)

Normal range:

150,000 to 450,000 per microliter of blood

What do the test results mean?

A low platelet count is called thrombocytopenia which means the platelet count is less than 150,000. This may be due to:

  • Decreased platelet production
  • Destruction of platelets in the blood
  • Destruction of platelets in the spleen or liver
RESULTS POSSIBLE CAUSES

Low platelet count (< 150,000)

Idiopathic thrombocytopenia (ITP) or Immune thrombocytopenic purpura, are Autoimmune disorders where the immune system makes antibodies against platelets.
Chemotherapy or radiation therapy
Drug induced decrease may be due to aspirin and ibuprofen, some antibiotics (including those containing sulfa), colchicine and indomethacin, H2-blocking agents, hydralazine, isoniazid, quinidine, thiazide diuretics, and tolbutamide.
Heparin-induced thrombocytopenia (HIT) when a person who is on or received heparin therapy develops an antibody. 
Viral infections such as mononucleosishepatitisHIV or measles. Mosquito-borne diseases such as dengue, chhikungunya or malaria.
Leukaemialymphoma, or any cancer that may have spread (metastasized) to the bone marrow. Increased cancer cells in the bone marrow affect platelet production. 
Aplastic anemia—a blood disorder where the bone marrow does not make enough new blood cells.
GI bleeding due to chronic stomach ulcers, polyps etc.
Cirrhosis- scarring of the liver
Sepsis-life-threatening bacterial infection in the body.
Platelet destruction due to conditions like and hemolytic uremic syndrome (HUS), disseminated intravascular coagulation (DIC), or thrombocytopenic purpura (TTP).
Toxic chemical (arsenic, benzene, pesticides etc) exposure 
   

*If the platelet count drops below 20,000 per microliter the patient is at severe risk of spontaneous bleeding. At this point platelet transfusion may be required.

A high platelet count is called thrombocytosis or thrombocythemia which means the platelet count is above 450,000. This may be due to:

  1. Primary Thrombocythemia where too many or abnormal platelets are produced by the bone marrow. In the absence of any blood disorders, it is called Essential Thromocythemia. It can even be due to a genetic JAK2 mutation.
  2. Secondary Thrombocythemia is where an external factor causes high platelet production.
RESULTS POSSIBLE CAUSES

Low platelet count (< 150,000)

Primary Thrombocythemia

Myeloproliferative disorder such as Polycthemia vera, Chronic Myeloid leukemia etc.

Von Willebrand disease
Secondary Thrombocythemia

Iron deficiency or Hemolytic anemia

Cancer of the lung, GI tract, ovary, breast or blood.

Absence of a spleen.

Inflammatory diseases such as IBS, or Rheumatoid arthritis.

Infectious diseases like Tuberculosis

Certain medications such as Oral contraceptives.
Transient Thrombocythemia ( lasting for only a short period)

Recovery after major blood loss

Alcohol binge

Vitamin B12 or folate deficiency

Strenuous exercise/activity

Recent acute infection
     

Mean Platelet Volume or MPV:

This is the measurement of the average size of platelets circulating in the blood. This result helps evaluate production or destruction of platelets if any in the blood. Young platelets produced by the bone marrow are larger in size then the older platelets.

Normal range of MVP is 7.5-11.5 femtoliter

 

RESULTS WHAT IT MEANS POSSIBLE CAUSES
High MPV (larger size platelets) Body is making new platelets! This increases clotting tendencies and risk of stroke or thrombosis. Recent infection, surgery or blood loss.
Low MPV (smaller size platelets) Body is not making new platelets! This increases risk of bleeding. Bone marrow disorders like aplastic anemia, Chronic kidney failure, sepsis, enlarged spleen or toxic drugs.
       

**A result of normal platelet count with High MPV is a sign of Idiopathic thrombocytopenic purpura, hyperthyroidism or chronic myeloid leukaemia! This indicates that the bone marrow is producing platelets but they are getting destroyed.

Changed
22/Sep/2019

Stories

  • Esophageal Cancer Made Swallowing Of Even Ice Cream Hard
    When Mr. Sudhir Waghmare, 58, PhD, entrepreneur and innovator, was diagnosed with esophageal cancer he took it in his stride quite stolidly. What broke him down was the loss during chemotherapy of his luscious hair which he dearly cherished. He shares his personal narrative. My background I am an entrepreneur and innovator of a company engaged in manufacturing new born life saving devices since the last 31 years. I have a PhD degree in Neonatal Intensive care equipment. I am married to…
  • मैं कैंसर से नहीं मरूंगी
    मुंबई की 56 वर्षीय रश्मि सचदे को 15 साल पहले गैस्ट्रोइंटेस्टाइनल स्ट्रोमल ट्यूमर (जीआईएसटी) का निदान मिला था। वे कैंसर को एक पेइंग गेस्ट की तरह मानती हैं और अपनी कैंसर यात्रा को अपनी आस्था और हँसते रहने की प्रवृत्ति के सहारे संभालती हैं। 2004 की बात है।, मैंने देखा कि मेरा पेट फूलने लगा था और जब मैं सोने के लिए लेटती तो विशेष रूप से एक तरफ बहुत सख्त लगता। मुझे उस समय फूले हुए पेट के अलावा कोई अन्य स्वास्थ्य संबंधी शिकायत नहीं थी – पर पेट इतना फूला रहता कि लोग पूछने लगे कि क्या मैं गर्भवती हूं।…
  • Profile picture of Uday Kerwar Bladder cancer survivor and Ostomy India Chairperson framed in a blue background with the bladder cancer tricolour ribbon
    You Adapt To The Bladder Bag Like You Do To Eye-Glasses
    Uday Kerwar, survivor of stage 4 bladder cancer and currently Chairman of Ostomy Association of India (OAI) talks about his journey with bladder cancer, urostomy bags, its many challenges and plenty of adjustments before it becomes a part of you. Please tell us a little about yourself.  I am 62 and retired. Since 2016 I am continuously associated with Ostomy Association of India (OAI), a Charitable Trust providing rehabilitative support to people who have undergone Ostomy (life-saving…
  • Head shot of a bespectacled woman wearing a black and red dress and red necklace
    मेरे ब्रेन ट्यूमर के निदान ने मुझे बोल्ड बना दिया
    जब बेंगलुरु की 38 वर्षीया ए चित्रा को सीज़र होने लगे, तो शुरू में उनका एपिलेप्सी (मिर्गी) के लिए इलाज किया गया, लेकिन अंततः उन्हें मैलिग्नेंट ग्लियोमा (एक प्रकार का ब्रेन ट्यूमर) का निदान मिला। वे बताती हैं कि कैसे उन्होंने डॉक्टरों, परिवार, दोस्तों और अपनी कंपनी की टीम के समर्थन से अपनी बीमारी के उपचार और भावनात्मक पीड़ा को संभाला। कृपया हमें अपनी स्थिति के बारे में कुछ बताएं मुझे एनाप्लास्टिक एस्ट्रोसाइटोमा ग्रेड 3 नामक ब्रेन ट्यूमर का निदान मिला था। यह एक दुर्लभ, मैलिग्नेंट ट्यूमर है जिसे…
  • ब्रेन ट्यूमर होने के बाद मेरी पहली प्राथमिकता मेरा स्वास्थ्य है
    30 वर्षीय मेल्विन जॉर्ज इस लेख में एस्ट्रोसाइटोमा (एक प्रकार का ब्रेन ट्यूमर) का निदान प्राप्त करने, देखभाल के विकल्पों का आकलन करने और निर्णय लेने, और कैंसर के उपचार और सम्बंधित दुष्प्रभाव पर चर्चा करते हैं और साझा करते हैं  कि इन सब अनुभव और चुनौतियों ने उन्हें व्यक्तिगत रूप से कैसे प्रभावित किया और रिकवरी में उनकी आस्था उनका मुख्य सहारा कैसे बनी रही।  चौंकाने वाला निदान 11 जुलाई 2017 का दिन। मैं अपने छात्रावास के कमरे में अपने बिस्तर पर लेटा हुआ था और जैसे ही मैं जाका, मैंने देखा…
  • The author, a woman in a red and yellow sari and a yellow blouse, holding birds
    मैंने अपनी आवाज पैसिव स्मोकिंग (निष्क्रिय धूम्रपान) के कारण खो दी
    धूम्रपान न करने वाली 72 वर्षीया नलिनी सत्यनारायण को 10 साल पहले उनके घर में सेकेंड हैंड धुएं के संपर्क में आने के कारण गले (वॉयस बॉक्स) के कैंसर का निदान मिला। आज, उत्तरजीवी के रूप में, वे एक ऊर्जावान तंबाकू नियंत्रण योद्धा बन गई हैं और ऐसे लोगों को परामर्श देती हैं जिन्होंने स्वरयंत्र (लैरिन्क्स) की सर्जरी करवाई है जिसमें उनका वॉयस बॉक्स हटाया गया है - वे उन्हें कृत्रिम वॉयस बॉक्स से बात करना सिखाती हैं। आपने कब और कैसे अपने गले की समस्या को पहचाना? जनवरी 2010 की बात है। मुझे लगा कि मेरा गला…
  • Should Time Toxicity Be A Factor In Informed Decision Making?
    Patients with advanced cancers often contemplate the time burden of their cancer care. What does this exactly entail? Dr Arjun Gupta, an Oncologist and Researcher, recently wrote a paper about Time Toxicity for Cancer patients. He helps us understand this new concept and how it can affect quality of life for patients. What is ‘’time toxicity’’? We have seen tremendous progress in oncology in the past few decades. Yet, for advanced solid cancers, average survival benefits offered by new…
  • Webinar: Ovarian Cancer Awareness and Management
    This webinar is not just for Ovarian Cancer survivors but also for survivors of breast cancer, uterine cancer, colorectal cancer and all women at risk of Ovarian Cancer. Ovarian Cancer is a difficult to diagnose cancer. So it is very important for us to be aware of the surprising symptoms of Ovarian cancer. We must also know the factors that increase risk. Additionally, in COVID times, it is important to understand how to continue treatment and when you should vaccinate. We bring together a…
  • A panel discussion on Kidney Cancer with the profile pictures of the panelists
    Demystifying Kidney Cancer : Key Webinar takeaways
    Renal cell carcinoma is the most common type of adult kidney cancer, making up about 85% of diagnoses. And yet it is rarely talked about.  Kidney Cancer is also an area which has seen significant progress in treatment options. Key takeaways from the webinar are given below.  An expert panel talked about kidney cancer and answered questions and concerns that patients have. The panelists are Dr. KL Jayakumar, MD Radiation Oncology. Professor and HOD, Sreemookambika Cancer center,…
  • Webinar: Towards Patient Centred Access To Quality Cancer Care - Challenges
    PatientsEngage and EHA Consortium invite you to an interactive webinar series on Patient Centred Access to Quality Cancer Care. In the first of the series aligned to the UICC theme of "Close the Care Gap", we are very privileged to have an esteemed and diverse panel who will highlight the challenges faced in equitable access to quality cancer care and identify the areas where we still need to make progress. The panelists are Dr. CS Pramesh, Director Tata Memorial Hospital; Convener National…